Abstract
Introduction: We examined relationships of body mass index (BMI) with cognition in middle-aged adults at Alzheimer's disease (AD) risk due to parental family history. Methods: Participants are offspring of AD patients from the Israel Registry of Alzheimer's Prevention (N = 271). Linear regressions assessed associations of BMI and cognition, and whether associations differed by maternal/paternal history. Analyses of covariance examined associations of long-term trajectories of BMI with cognition. Results: Higher BMI was associated with worse language (P =.045). Interactions of BMI with parental history were significant for episodic memory (P =.023), language (p =.027), working memory (P =.006), global cognition (P =.008); associations were stronger among participants with maternal history. Interactions of BMI trajectories with parental history were significant for episodic memory (P =.017), language (P =.013), working memory (P =.001), global cognition (P =.005), with stronger associations for maternal history. Discussion: Higher BMI and overweight/obese trajectories were associated with poorer cognition in adults with maternal history of AD, but not those with paternal history.
Original language | English |
---|---|
Article number | e12247 |
Journal | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association
Funding
Rebecca K. West reports that in addition to her work at the Icahn School of Medicine at Mount Sinai, she is paid as an adjunct assistant professor and a researcher at the City University of New York. Ramit Ravona‐Springer received funding from Tel Aviv University internal grants—the Brecher foundation and the Ofer Mordechai Foundation, the ARC (Accelerate, Redesign, Collaborate) Innovation Center at the Sheba Medical Center, the ADDF (Alzheimer's Drug Discovery Foundation). Inbal Sharvit Ginon received travel support for attending AAIC 2018 and AAIC 2019, as PhD student at the Joseph Sagol Neuroscience Center at Sheba Medical Center, Israel. Ithamar Ganmore reports no disclosures. Sigalit Manzali reports no disclosures. Sapir Golan reports no disclosures. Ethel Boccara reports no disclosures.Anthony Heymann received consulting fees from pharmaceutical companies Boehringer Ingelheim Israel, Rafa Israel, and Kamada, and payment for expert testimony in medical negligence cases in Israel courts. Michal Schnaider Beeri reports no disclosures. Study funded by NIH (AG02219/AG/NIA NIH HHS, P01‐AG02219/AG/NIA NIH HHS, R01 AG034087/AG/NIA NIH HHS, AG051545/AG/NIA NIH HHS, AG053446/AG/NIA NIH HHS, AG061093/AG/NIA NIH HHS), provided to the institutions listed in this manuscript. We thank the LeRoy Schecter Foundation and Dr. Marina Nissim for their kind financial gifts that supported this study. Study funded by NIH (AG02219/AG/NIA NIH HHS, P01-AG02219/AG/NIA NIH HHS, R01 AG034087/AG/NIA NIH HHS, AG051545/AG/NIA NIH HHS, AG053446/AG/NIA NIH HHS, AG061093/AG/NIA NIH HHS), provided to the institutions listed in this manuscript.
Funders | Funder number |
---|---|
Brecher foundation | |
LeRoy Schecter Foundation | |
NIH HHS | P01‐AG02219/AG/NIA |
Ofer Mordechai Foundation | |
Sheba Medical Center | |
National Institutes of Health | |
Alzheimer's Drug Discovery Foundation | |
Automotive Research Center | |
Tel Aviv University |
Keywords
- Alzheimer's disease
- adiposity
- cognition
- cognitive decline
- obesity
- parental history of Alzheimer's disease
- risk factors